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Bdellovibrio bacteriovorus is a bacterium which preys upon and kills Gram-negative bacteria, including the
zoonotic pathogens Escherichia coli and Salmonella. Bdellovibrio has potential as a biocontrol agent, but no
reports of it being tested in living animals have been published, and no data on whether Bdellovibrio might
spread between animals are available. In this study, we tried to fill this knowledge gap, using B. bacteriovorus
HD100 doses in poultry with a normal gut microbiota or predosed with a colonizing Salmonella strain. In both
cases, Bdellovibrio was dosed orally along with antacids. After dosing non-Salmonella-infected birds with
Bdellovibrio, we measured the health and well-being of the birds and any changes in their gut pathology and
culturable microbiota, finding that although a Bdellovibrio dose at 2 days of age altered the overall diversity of
the natural gut microbiota in 28-day-old birds, there were no adverse effects on their growth and well-being.
Drinking water and fecal matter from the pens in which the birds were housed as groups showed no
contamination by Bdellovibrio after dosing. Predatory Bdellovibrio orally administered to birds that had been
predosed with a gut-colonizing Salmonella enterica serovar Enteritidis phage type 4 strain (an important
zoonotic pathogen) significantly reduced Salmonella numbers in bird gut cecal contents and reduced abnormal
cecal morphology, indicating reduced cecal inflammation, compared to the ceca of the untreated controls or a
nonpredatory pilA strain, suggesting that these effects were due to predatory action. This work is a first step
to applying Bdellovibrio therapeutically for other animal, and possibly human, infections.
Bdellovibrio bacteriovorus is a small predatory deltaproteo-
bacterium which invades and kills other Gram-negative bacte-
ria, including a broad range of pathogens of vertebrates and
humans (48, 57). In an age of increasingly problematic con-
ventional antibiotic resistance in major human pathogens, such
as Escherichia coli ST131 and others, Bdellovibrio could be of
great use as a potential so-called living antibiotic (43, 52).
Since its discovery in the 1960s (55), there have been no
reports of trials of Bdellovibrio use against such pathogens
within warm-blooded animals, and there are only a few reports
of it being used in environmental applications to plants and in
fish farming (29, 38, 63). Some limited studies were carried out
previously to try to test the safety of Bdellovibrio by feeding it
to amphibians via an intragastric tube and by ex vivo tests in
isolated rabbit ileal loops (63), and there are previous reports
in the literature of Bdellovibrio being isolated from the intes-
tinal contents of live animals and humans (47). Several in vitro
studies recently have been published (14, 15, 60) looking at the
susceptibility of human pathogens to predation by Bdellovibrio,
and these have shown that Bdellovibrio is able to successfully
reduce pathogen numbers under laboratory conditions.
With increasing antibiotic resistance being reported for
Gram-negative pathogens, including the emergence of intesti-
nal and uropathogenic E. coli ST131 (27), which are resistant
to fluoroquinolone and extended-spectrum -lactam antibiot-
ics, we felt that it was important to begin assessing the poten-
tial of Bdellovibrio therapy experimentally by performing in
vivo experiments using Bdellovibrio inside living, warm-blooded
vertebrates.
In addition to assessing the beneficial aspects of Bdellovibrio
therapy, we wished to monitor any potential health problems
created by the application of Bdellovibrio, either by directly
invading mammalian cells (although this is not thought to
occur and has been tested in one previous report [35]) or due
to the broad prey range of Bdellovibrio causing a harmful
imbalance of the normal gut microbiota (dysbiosis). The idea
of these studies was to see the effects upon normal gut micro-
biota of ingesting Bdellovibrio, so that whether they are to be
applied in the future as topical agents for wound infections, or
indeed any oral infection applications, the potential effects
internally of even accidental ingestion would be known. The-
oretically Bdellovibrio could be detrimental to Gram-negative
gut microbiota and thus the eukaryotic host’s well-being, in-
tentionally or not, as it kills such Gram-negative cells and they
contribute to animal nutrition.
We chose poultry as our model vertebrates, both to study
whether Bdellovibrio had any effect on animal well-being and
also because this is a well-studied model used in Salmonella
infection and intestinal/cecal colonization experiments (22, 39,
62), which would allow us to determine any therapeutic effects
of Bdellovibrio treatment. The model of Salmonella in poultry
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was chosen for several additional reasons: first, and impor-
tantly for animal welfare, Salmonella enterica serovar Enterit-
idis often infects poultry, particularly laying hens, without clin-
ical symptoms (13), unlike serovars such as Gallinarum, the
agent responsible for fowl typhoid (11).
Our experimental model used S. Enteritidis P125109, a ge-
nome-sequenced representative of phage type 4 (PT4), which
was largely responsible for the significant increase in reported
cases of human salmonellosis in England and Wales during the
1980s and 1990s (12) and continues to be the main S. Enter-
itidis phage type isolated from humans in the European Union
(17). Elsewhere, Salmonella remains a major public health
concern, as shown recently in a U.S. Food and Drug Admin-
istration report on the recall of more than half a billion eggs
that were suspected to be contaminated with Salmonella En-
teritidis (10, 19). Finally, the model has been studied previ-
ously with respect to another biological therapeutic agent, bac-
teriophage (4, 7, 62), so some comparative data exist on the in
vivo reduction of pathogens by sampling and enumerating the
Salmonella load in cecal contents of bird guts. At the outset of
our studies we verified in the laboratory that the Salmonella
strain was efficiently invaded by B. bacteriovorus HD100.
Predacious life in the gastrointestinal tract of poultry pres-
ents a variety of challenges to Bdellovibrio: the body tempera-
ture of a chicken is typically 42°C, whereas Bdellovibrio is
routinely grown at an optimal temperature of 29°C (as found in
early attachment studies [61]). In addition, the hypoxic or an-
oxic environment of the bird gut places additional pressure on
Bdellovibrio, which is typically aerobically grown in the labora-
tory, although a single study has shown the survival of several
Bdellovibrio strains in anaerobic conditions for up to 9 days
(46). In our experiments, we used the genome-sequenced type
strain B. bacteriovorus HD100, a strain that originally was iso-
lated from soil and has been used in many laboratory-based
predation studies (18, 25, 30, 44). Although it will be possible
in the future to try to isolate Bdellovibrio from animal guts and
study them, more is known physiologically and genetically
about strain HD100 at this stage than about any other strain.
Our model system also allowed us to assay other potential
side effects of Bdellovibrio therapy: by orally dosing the chicks,
we were testing the effects of the ingestion of large numbers of
Bdellovibrio, and this informed us of any possible adverse ef-
fects of accidental ingestions were Bdellovibrio to be used in
future applications to surface wound dressings. In addition, we
included an environmental monitoring element, where the
birds were housed in groups in large normal pens (in contained
rooms) with bedding on the floor and shared drink and food
trays; thus, we were able to determine whether there was any
spread of Bdellovibrio after dosing.
This study has shown that B. bacteriovorus HD100 is able to
overcome many of the difficulties presented by the model of
the Salmonella colonization of chicken intestine, including
that, possibly contrary to expectations, aerobic B. bacteriovorus
HD100 does survive anaerobic/microaerobic incubation at
42°C, whether inside prey bacteria or incubated alone, and
although their reisolation from gut contents after administra-
tion was sporadic at best, suggesting short-lived survival, they
have measurable and significant positive effects in vivo. Our
work suggests that the reduction of cecal abnormalities, as well
as the lowering of Salmonella numbers, were the result of the
predatory action of Bdellovibrio and not just its live competitive
metabolism or action as a dead inert source of organic nutri-
ents in the gut environment.
This is the first report of a complete live-animal treatment
with Bdellovibrio, and the lack of any negative side effects
bodes well for future therapeutic trials.
MATERIALS AND METHODS
Bacterial strains, maintenance, and enumeration. E. coli S17-1 was routinely
used as prey to maintain predatory cultures of Bdellovibrio (31, 33). E. coli S17-1
was grown in YT (0.5% Difco Bacto yeast extract, 0.5% NaCl, 0.8% Difco Bacto
tryptone, pH 7.5) broth (31, 34) at 37°C with shaking at 200 rpm for 16 h before
it was used in a late-log-phase culture for addition to Bdellovibrio. Salmonella
Enteritidis P125109 also was grown in YT broth under the same conditions as
those for E. coli, also yielding a late-log-phase culture for use with Bdellovibrio.
Host-dependent (HD) Bdellovibrio bacteriovorus HD100 (43, 55) was grown in
predatory cultures consisting of Ca-HEPES buffer (25 mM HEPES, 2 mM
CaCl2, pH 7.6), late-log-phase prey (either E. coli S17-1 or S. Enteritidis
P125109, produced as described above), and a previously grown Bdellovibrio
culture in a ratio of 50:3:1 (vol/vol/vol). The complete lysis of prey typically was
achieved within 24 h when grown on E. coli S17-1, and almost complete lysis (see
the next section) occurred in 48 h when grown on Salmonella Enteritidis P125109
as prey. Host-independent (HI) derivatives were grown in PY broth (18, 49) and
derived as described by Evans et al. (18). Bdellovibrio (both HD and HI) was
grown aerobically at 29°C with shaking at 200 rpm.
HD Bdellovibrio viable counts were made using double-layer YPSC (0.1%
Difco yeast extract, 0.1% Difco Bacto peptone, 0.05% MgSO4  7H2O, 0.025%
CaCl2  2H2O, pH 7.6) (31) agar plates as described elsewhere (25, 34). E. coli
was enumerated on YT plates (25), and S. Enteritis was enumerated on YT (for
in vitro experiments) or on modified brilliant green agar (CM0329; Oxoid) plates.
Testing Bdellovibrio in vitro: predation of Salmonella Enteritidis versus that of
E. coli. Bdellovibrio bacteriovorus HD100 (43, 55) is routinely used in laboratory
conditions to prey upon E. coli strains, such as ML35 and S17-1 (50), but in later
in vivo experiments the prey was Salmonella Enteritidis strain P125109 (58).
Thus, Bdellovibrio predation efficiency on this strain of Salmonella and its entry
into this prey was verified.
Bdellovibrio entry into prey was visualized using electron microscopy. Cultures
consisting of 2 ml of a Bdellovibrio predatory culture (which had completed prey
lysis and typically contained 2.5  108 PFU ml1) and 300 l of a 16-h Salmo-
nella culture (grown to late log phase in YT broth aerobically at 37°C for 16 h)
were incubated for 15 min at 29°C before grids were prepared. Cells were stained
with 0.5% uranyl acetate (URA), pH 4.0, and imaged using a JEOL JEM 1010
electron microscope as described previously (18, 20).
The comparison of Bdellovibrio predation rate and efficiency on different prey
was achieved by measurements of the optical density at 600 nm (OD600) using a
Fluostar Optima plate reader (BMG Labtech). Predatory cultures of B. bacte-
riovorus HD100 which had completed prey lysis were split, with half being heat
killed by incubation at 105°C for 5 min and then cooled to room temperature.
Sixty-four l of either live predatory Bdellovibrio or heat-killed Bdellovibrio cells
was added to wells of a 96-well Optiplate (Porvair Sciences Ltd.). To this, 200 l
of a prey and buffer mix was added, which consisted of 10 ml of Ca-HEPES buffer
and 400 l of a 16-h culture of either E. coli S17-1 or S. Enteritidis P125109. The
plate then was sealed with a Breathe-Easy (Web Scientific) gas-permeable seal-
ing membrane and incubated in the Fluostar plate-reader at 29°C with shaking at
200 rpm for 24 h, with an OD600 reading every 1 h. The initial enumerations of
both Bdellovibrio and prey were made as described above, and prey again were
enumerated (from wells containing live Bdellovibrio) upon the completion of the
incubation time.
In vitro Bdellovibrio survival at 42°C microaerobically and anaerobically. To
verify that Bdellovibrio would survive conditions in the bird gut, in vitro tests were
set up. B. bacteriovorus HD100 was pregrown for 24 h in a typical predatory
culture consisting of 150 ml Ca-HEPES buffer, 9 ml of a E. coli S17-1 culture
grown for 16 h, and 3 ml of a Bdellovibrio predatory culture. Experimental
cultures were set up initially in 500-ml conical flasks containing Bdellovibrio-only
controls (50 ml Bdellovibrio starter culture and 68 ml Ca-HEPES), Bdellovibrio
with E. coli cultures (50 ml Bdellovibrio starter culture, 18 ml of a 16-h E. coli
S17-1 culture, and 50 ml Ca-HEPES), and Bdellovibrio with Salmonella cultures
(50 ml Bdellovibrio starter culture, 18 ml of a 16-h S. Enteritidis P125109 culture,
and 50 ml Ca-HEPES). These starter cultures were incubated aerobically at 29°C
with shaking at 200 rpm for 1 h, allowing the Bdellovibrio organisms time to
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attach to and enter prey cells in the mixed cultures, forming stable bdelloplast
structures.
After the 1-h incubation, the cultures were placed in 5-ml aliquots in tissue
culture flasks with vented lids (25-cm2 polystyrene tissue culture flasks with PE
vented cap; Sarstedt) and then incubated under the following conditions (all
without shaking): at 29°C aerobically, at 42°C aerobically, at 42°C microaerobi-
cally (within a 7-liter gas-sealed box [Mitsubishi, bioMe´rieux Corporation] con-
taining CampyGen gas packs [CN0035A, Oxoid]), and at 42°C anaerobically
(again within a 7-liter gas-sealed box containing AnaeroGen gas packs
[AN0035A; Oxoid]). One sealed box was used for each survival sampling point,
with each box containing a flask of each experimental culture, and a flask was set
up for each time point for aerobic incubations. Each flask was used once.
At each time point tested, 1, 4, 24, 48, and 72 h after incubation at 42°C (or
29°C for the control samples), 100 l of each sample was spotted onto a YPSC
double-layered prey lawn overlay plate (25, 34) on which the top layer agar had
been inoculated with E. coli S17-1. The plates then were incubated agar side
down at 29°C until areas of clearing appeared on the plates inoculated with
samples from Bdellovibrio flasks incubated at 29°C aerobically. Zones of clearing
for the different conditions were compared to those of the control (see Fig. S1 in
the supplemental material).
Construction of a silent-deletion pilA Bdellovibrio mutant strain. In previous
work, a kanamycin resistance cassette disruption of the pilA gene in B. bacterio-
vorus was shown to result in the complete loss of predatory ability (18). For our
experiments to show whether predatory Bdellovibrio activity or merely the pres-
ence of live metabolizing Bdellovibrio, or dead Bdellovibrio biomass, was affecting
the outcomes, we required a nonpredatory Bdellovibrio strain which did not
contain any antibiotic resistance cassettes or engineered foreign DNA. Thus, we
produced a silent-deletion version of the pilA mutant in B. bacteriovorus
HD100, using an adaptation of the method described by Steyert and Pineiro (54).
One kb of flanking DNA from either side of the pilA gene was amplified and
joined together to give an in-frame deletion of the pilA open reading frame
(ORF) (retaining the start codon, the final three codons, and the stop codon).
This then was ligated into the kanamycin-resistant suicide vector pK18mobsacB
(23, 45) and conjugated into B. bacteriovorus HD100 (as described previously
[18]). pK18mobsacB previously has been shown to recombine into the B. bacte-
riovorus HD100 chromosome and to be suitable for making gene knockouts (20,
44). The resulting merodiploid exconjugants were grown with kanamycin selec-
tion in predatory cultures before being turned HI by culture on complete pep-
tone yeast extract (PY) medium without prey (18, 34). At the time of being
turned HI the antibiotic selection was removed; the resulting HI cultures were
screened by both PCR and Southern blotting (53) to verify the pilA gene deletion
and the absence of the suicide plasmid. The resulting pilA strain was confirmed
to be nonpredatory by the fluorescent prey assay described in detail previously
(18).
Preparation of Salmonella and Bdellovibrio for orally dosing birds. Salmonella
Enteritidis P125109 was grown in 50 ml of YT broth containing nalidixic acid
(which is selective for the strain) at 25 g ml1 under standard conditions. This
culture then was washed twice. The cells were centrifuged at 5,100 g for 10 min
and then resuspended in 50 ml of maximum recovery diluent (MRD; CM0733;
Oxoid); this step was repeated. The suspension then was diluted to an OD600 of
0.34 in MRD, 100 l of which then was given by oral gavage to each 2-day-old
chick. Subsequent enumeration of the Salmonella in these suspensions, by viable
counting on modified brilliant green agar plates with nalidixic acid (CM0329;
Oxoid), showed that each chick received an average Salmonella count of 3.16 
107 CFU (per 100 l dose). This had been shown in our earlier experiments (data
not shown) to give consistent colonization of the chicks’ gastrointestinal tract by
the Salmonella organisms.
Host-dependent (HD) B. bacteriovorus HD100 was grown in a predatory
culture containing 500 ml Ca-HEPES buffer, 30 ml of a 16-h prey culture, and 50
ml of a 24-h predatory culture of Bdellovibrio, and then it was incubated at 29°C
with shaking at 200 rpm for 48 h. The prey used in these cultures depended upon
the trial in which they were used. For the bird well-being trials, Bdellovibrio was
pregrown on E. coli S17-1 to eliminate any possibility of introducing any surviving
S. Enteritidis into the chicks along with the Bdellovibrio organisms, which could
have caused significant changes to the birds’ health and well-being. For the
therapeutic trials, where the birds were precolonized with S. Enteritidis, the
introduction of a small number of Salmonella cells with Bdellovibrio did not pose
such a problem, so for these trials the Bdellovibrio organisms were grown using
S. Enteritidis P125109 as prey.
After the 48-h incubation period, the cultures were checked microscopically
for prey lysis and filtered once through a 0.45-m-pore-size filter to remove any
remaining prey cells, and then the Bdellovibrio organisms were pelleted (in 50-ml
Falcon tubes) by centrifugation at 5,100 g at 29°C for 30 min. The supernatants
were decanted, and the Bdellovibrio organisms were resuspended in the residual
liquid. The cells then were diluted 10-fold in fresh Ca-HEPES buffer, giving an
average Bdellovibrio count of 9.8  107 PFU per 100-l dose (as determined
after the experiments due to Bdellovibrio forming plaques only after at least 5
days on an overlay plate).
The host-independent (HI) B. bacteriovorus pilA mutant was grown as de-
scribed above in 50 ml PY broth for 24 h. Forty ml of HI cells was pelleted by
centrifugation at 5,100  g at 29°C for 20 min, resuspended in 20 ml Ca-HEPES
buffer, and centrifuged again before being resuspended in 40 ml of fresh Ca-
HEPES buffer. HI doses were matched to their comparable HD dose by protein
content using a Lowry assay (37). The protein assay was used because it is rapid
(not requiring several days of growth to enumerate HD plaques or HI colonies
on plates) and matches cell biomass for Bdellovibrio organisms, which are too
small to give a reliable optical density reading and thus cannot be enumerated by
the OD600.
HD Bdellovibrio doses were enumerated (after use) as viable counts by plaque
formation on YPSC prey overlay plates (25, 34); any remaining Salmonella
survivors in the inocula (which were very few) were enumerated on modified
brilliant green agar plates (CM0329; Oxoid), and HI Bdellovibrio organisms were
enumerated on PY agar plates (18, 34, 49). The inocula were transported to the
animal facilities within 1 h. Previous experiments (data not shown) showed
that the viability of the Bdellovibrio strains under these conditions did not
significantly alter. Immediately prior to dosing, 10 ml of each dose (or Ca-
HEPES buffer-only control) was added to 1.43 g CaCO3 to act as an antacid
protectant for the inoculum as it passed through the birds’ crops and mixed
to give a homogenous suspension; 100 l of this suspension then was given by
oral gavage to each chick.
Bdellovibrio and bird well-being experimental setup. Day-old Hy-line brown
male chicks from a layer hen line (Hy-line Hatcheries, Warwickshire, United
Kingdom) were separated at random into two groups of 12 (control and treated).
Each group of 12 chicks was housed inside a single-floor pen in a separate room
and individually identified using colored markings. The birds were provided with
food and water ad libitum. Cage temperature was 32°C for the first 3 days and
30°C after that. At 2 days of age, the birds in the treated group each received 100
l of a 1.9  107 PFU ml1 suspension of Bdellovibrio bacteriovorus HD100 in
Ca-HEPES buffer (pregrown on E. coli S17-1 as prey so as to eliminate any
potential of Salmonella being introduced into the chicks with the Bdellovibrio)
containing 14% (wt/vol) CaCO3 by oral inoculation; the birds in the control
group received 100 l of Ca-HEPES buffer with CaCO3 only. Following inocu-
lation, the birds were observed for any signs of ill health (e.g., lethargy, hunched
posture, ruffled feathers, drooping wings, weight loss, abnormal excreta, and
pasty vent) twice daily using the score sheet proposed by the BVAAWF/
FRAME/RSPCA/UFAW Joint Working Group on Refinement (24). The birds
in each group were weighed every day following (and including) the day of
Bdellovibrio challenge, and these data were compared to industry standards for
these birds (26). A pool of three freshly voided fecal samples and a separate
10-ml sample of water from the drinking trough were collected from each group
at regular intervals throughout the trial (48- to 72-h intervals) for the enumer-
ation of bacterial populations (see below). At 4 weeks of age, the birds were
sacrificed and populations of various bacterial genera enumerated from the cecal
contents (see below). Ceca are the conventional site of choice for the enumer-
ation of Salmonella in the guts of poultry (rather than the whole gut), as they are
an anatomically discrete compartment where Salmonella colonizes. Ceca can be
readily tied off and isolated without the loss of contents and are less subject to
differences to which the whole gut is susceptible, such as differing recent inputs
or outputs due to episodes of eating food or defecation (22).
Examination of drinking water and fecal and cecal samples. Fecal and cecal
samples were decimally diluted in Ca-HEPES buffer (for Bdellovibrio enumera-
tion) or MRD (CM0733; Oxoid) for all other bacterial populations. For Bdel-
lovibrio enumeration, fecal/cecal suspensions first were filtered through a 0.45-
m-pore-size filter, and then 100 l of filtrate was added to the top layer of a
double-layer YPSC plate (as described above) with E. coli S17-1 as prey. Plates
were incubated at 29°C aerobically for a minimum of 5 days.
Other bacterial populations were enumerated by spread plating 100 l of 101
to 108 dilutions (dilution ranges varied according to the target bacterial pop-
ulation) in duplicate onto selective agar. The selective agars used (and target
bacterial populations) were modified brilliant green agar (Salmonella spp.;
CM0329 and sulfamendalate supplement [SR0087]); mitis salivarius agar (fecal
streptococci 229810 plus tellurite supplement 211917; Becton Dickinson, Oxford,
United Kingdom); modified charcoal cefoperazone deoxycholate agar (mCCDA;
Campylobacter spp.; CM0739 plus Campylobacter selective supplement SR0155);
Rogosa agar (Lactobacillus spp.; CM0627; Oxoid); bifidus selective medium
(Bifidobacterium sp.; 88517 plus BSM supplement 83055; Sigma); Columbia
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blood agar with 100 g ml1 neomycin trisulfate (anaerobic bacteria; CM0331;
Oxoid); and chromogenic (brilliance) E. coli/coliform agar (CM0956). The plates
were incubated under the following conditions: brilliant green and chromogenic,
37°C for 24 h; and mCCDA and Rogosa, 42°C for 48 h under microaerobic
conditions (5% H2, 5% O2, 10% CO2, 80% N2). The remaining plates were
incubated at 37°C for 48 h under anaerobic conditions (5% CO2, 5% H2,
90% N2).
Bdellovibrio therapeutic trial experimental setup. For each biological repeat,
day-old male Hy-line brown chicks were separated at random into two (trial 1)
or three (trial 2) groups of 18 birds. Each group of 18 chicks was placed in a
separate room inside a single-floor pen and provided with food and water ad
libitum. For both trial 1 and trial 2, all birds received a 100-l dose of Salmonella
Enteritidis P125109 (prepared as described above) by oral gavage, containing an
average Salmonella count of 3.16  107 CFU per dose.
In trial 1, 10 days after the Salmonella challenge, the birds in the first group
received 100 l of a 9.8  107 PFU ml1 suspension of predatory Bdellovibrio
bacteriovorus HD100 (pregrown as described above with S. Enteritidis as prey)
containing 14% (wt/vol) CaCO3 as an antacid; the second group received 100 l
of Ca-HEPES buffer containing 14% (wt/vol) CaCO3. For trial 2, the first two
groups were treated identically to those in trial 1. The remaining group was given
a nonpredatory B. bacteriovorus HI pilA mutant in Ca-HEPES buffer containing
14% (wt/vol) CaCO3. This was matched, by protein content, to the host-depen-
dent Bdellovibrio dose as explained above.
Bird numbers were chosen to allow for a minimum of 80% power to detect a
1-log10 difference between the group mean values based on a group size of 10. To
minimize the use of live birds in our research in this, we sought advice from
pathology statistician Alan J. Hedges (University of Bristol). Two biological
repeats were performed in each trial (i.e., four groups for trial 1 and six groups
for trial 2 in total). This gave 24 birds per day in total for the control and
predatory Bdellovibrio treatments and 12 birds per day for the HI pilA non-
predatory Bdellovibrio treatment.
Bdellovibrio therapeutic trials: examination and scoring of bird guts postmor-
tem. During the postmortem examination of the birds, very obvious differences
were seen in the appearance and contents of the ceca of the intestinal tract.
These differences meant that in abnormal ceca there were almost no dark
free-flowing gut contents to sample for bacterial counts, but that the ceca were
impacted with white/cream mucoid matter. This has been reported previously as
an inflammatory response with white blood cell infiltration caused by the Sal-
monella infection (1, 2, 16, 36, 42). Thus, we defined ceca as abnormal if they
were very pale and/or their contents were mucoid, solid, white, very watery yet
full and white, or weighed 0.1 g. We photographed and recorded examples of
these and scored each pair of ceca by these criteria.
Statistical treatment of results. The data from four independent biological
repeats for each control and Bdellovibrio-treated group were pooled prior to
statistical analysis (data from two biological repeats were pooled for nonpreda-
tory HI pilA mutant Bdellovibrio-treated groups). All bacterial counts were
transformed to log10 CFU g1 cecal contents. Statistically significant differences
in Salmonella counts from cecal contents were determined using a t test with
Welch’s correction (as recommended by Skovlund and Fenstad [51]). Cecal
content weights were analyzed for normality by the Kolmogorov-Smirnov test,
and subsequently they were analyzed for statistical differences by the nonpara-
metric Kruskal-Wallis test with Dunn’s post test. The statistical significance of
differences in the proportion of abnormal ceca between Bdellovibrio-treated and
control groups was determined using Fisher’s exact test. Statistical analyses were
performed using either GraphPad Prism (version 4.00 for Windows) or Graph-
Pad Instat (version 3.10 for Windows).
Ethical statement on bird experiments. All experiments involving the use of
animals were subjected to a National United Kingdom Government approval
process by the United Kingdom Home Office, which grants licenses for specific
work to specific individuals. Work on this project was approved under United
Kingdom Government Home Office Project Licensing ASPA86. All project li-
censes are reviewed internally by the University Ethics Committee prior to
submission to the Home Office. This includes the scrutiny of animal welfare,
ethics, and handling. All of our individual experiments were reviewed and ap-
proved by a member of the senior management committee within the School of
Veterinary Science at University of Nottingham, which was responsible for the
work. They also are scrutinized by the Named Veterinary Surgeon (NVS) and
the Named Animal Care and Welfare Officer (NACWO) before each experiment
is allowed to proceed. This ensures minimal numbers of animals used in proce-
dures and the highest standards of welfare and ethics.
RESULTS
In vitro predation by Bdellovibrio on Salmonella Enteritidis.
Bdellovibrio bacteriovorus HD100 is routinely grown in the lab-
oratory on E. coli (typically S17-1 or ML35) prey, and it is
known to be predatory against a wide range of Gram-negative
bacteria, but not all of them. Thus, before use against Salmo-
nella Enteritidis in vivo, its efficacy in in vitro experiments was
determined. When the predation efficiency of B. bacteriovorus
HD100 on S. Enteritidis P125109 was compared to predation
FIG. 1. (A) Predatory kill curves of E. coli S17-1 and S. Enteritidis
P125109 by B. bacteriovorus HD100. Curves show the optical density
(at 600 nm) of E. coli with heat-killed Bdellovibrio (solid squares), E.
coli with live predatory Bdellovibrio (open squares), Salmonella with
heat-killed Bdellovibrio (solid triangles), and Salmonella with live pred-
atory Bdellovibrio (open triangles). Predatory Bdellovibrio was added to
late-log-phase prey (either E. coli S17-1 or S. Enteritidis P125109),
diluted in Ca-HEPES buffer, and incubated aerobically at 29°C with
shaking at 200 rpm. A small amount of prey replication occurred due
to the carryover of remaining nutrients within the prey cultures, but
this growth was limited due to the dilution of the prey into the non-
nutrient Ca-HEPES buffer. The drop in OD600 reflects the successful
predation on, and lysis of, the prey cells both early (during the small
amount of prey growth) and later during the incubation period when
the prey cells entered stationary phase. Each point represents the
means from three biological repeats, and error bars show the standard
errors above and below the means. (B) A B. bacteriovorus HD100 cell
entering an S. Enteritidis P125109 prey cell. Cells were stained with
0.5% uranyl acetate (URA), pH 4.0. The scale bar represents 1 m.
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on E. coli S17-1 (as shown by a drop in the optical density of
the prey cells in Fig. 1A), E. coli was preyed upon slightly faster
than the Salmonella prey, although both reached a minimal
optical density within the 24-h study period. Endpoint enumer-
ations showed that although the E. coli population was reduced
to 0.02% of its starting population size, the Salmonella popu-
lation was reduced to 3.03%, thus showing that a considerable
reduction in the Salmonella population was achieved, albeit
not quite to the same extent as that of the E. coli population.
During the same time period, the cultures containing Salmo-
nella incubated with heat-killed Bdellovibrio were seen to in-
crease in optical density, whereas the optical density of E. coli
with heat-killed Bdellovibrio did not significantly alter during
the course of the experiment. Therefore, the lesser reduction
of the Salmonella populations by Bdellovibrio may be due in
part to the ability of Salmonella to act as a more efficient
scavenger and liberator of amino acids from the remnants of
both dead prey and dead Bdellovibrio. Bdellovibrio cells were
seen to efficiently enter Salmonella prey cells (Fig. 1B); entry
was observed approximately 15 min after addition to prey,
which is similar to the time previously noted for E. coli S17-1
prey (30, 32). Thus, while B. bacteriovorus HD100 does not
prey upon Salmonella Enteritidis as efficiently as the routinely
used E. coli, it is still an effective predator against Salmonella,
causing significant reductions of 97% of the original numbers
within 24 h within a buffered in vitro environment. As there are
always survivors reported from Bdellovibrio predation, this
predatory result was typical and suitable for the study of a
reduction in numbers in vivo.
Bdellovibrio survival at 42°C and in microaerobic and an-
aerobic conditions relative to that in bird gut conditions.
Bdellovibrio is routinely cultured aerobically at 29°C, and while
there has been a previous study showing survival in anoxic
environments for up to 9 days (46), we assayed the survival of
B. bacteriovorus HD100 both as attack-phase cells and inside
bdelloplasts made from either E. coli S17-1 prey cells or S.
Enteritidis P125109 cells at temperatures and gas conditions
that would be found within the ceca of the birds. After incu-
bation at 42°C, with and without oxygen or in a reduced-oxygen
microaerobic environment, Bdellovibrio survival was assayed by
the successful production of areas of clearing on lawns of prey
(see Fig. S1 in the supplemental material). B. bacteriovorus
HD100 was seen to survive both as attack-phase cells and
within bdelloplasts for up to 48 h of incubation at 42°C aero-
bically, microaerobically, and anaerobically. This shows that, in
buffered environments at least, Bdellovibrio should be able to
survive the temperature and reduced-oxygen environments
found within the gut. While these tests do not replicate the gut
conditions precisely, it was important to establish in vitro that
there was the expectation of survival of Bdellovibrio in the in
vivo bird guts prior to the in vivo tests.
Bdellovibrio and bird well-being: testing for any effects of
Bdellovibrio on bird health and behavior. The effect of Bdello-
vibrio treatment on the health of Hy-line brown layer chicks
was assessed for 28 days after inoculation by daily measure-
ments of weight and twice-daily assessments of any health or
behavioral abnormalities (according to the framework pro-
posed by the BVAAWF/FRAME/RSPCA/UFAW Joint Work-
ing Group on Refinement [24]). Bdellovibrio was given to the
birds at 2 days of age. Each bird received either 1.9 106 PFU
Bdellovibrio (per dose) resuspended in Ca-HEPES buffer with
14% (wt/vol) CaCO3 or a buffer with CaCO3 control. None of
the birds in either the control or Bdellovibrio-treated groups
exhibited any signs of ill health or behavioral abnormality dur-
ing the 4-week trial. Both groups gained weight (Fig. 2A) at or
above the industry guideline rate for this strain of bird when
FIG. 2. (A) Weight gain by control and Bdellovibrio-treated chickens. Birds were dosed with Bdellovibrio (treated) or buffer (control) at 2 days
of age and then weighed daily for the next 28 days. F, control; E, Bdellovibrio treated. (B) Scatter plot showing counts of bacterial populations from
the cecal contents of control (C) and Bdellovibrio-treated (T) chickens. A group of 12 Hy-line brown birds each were challenged orally with 100
l of approximately 1.9  107 PFU/ml of B. bacteriovorus HD100 at 2 days of age. An identical control group was challenged with Ca-HEPES
buffer. At 28 days postdose, the birds were sacrificed and targeted bacterial populations were enumerated on selective agar. Abbreviations: blood,
total anaerobic count on blood agar incubated under anaerobic conditions; bifido, bifidus selective agar; mitis, mitis salivarius agar; Rogosa, Rogosa
agar; chromogenic, chromogenic agar. Each data point represents counts of bacterial populations from the cecum of a single bird. The horizontal
lines represent the means for each group.
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housed in industry-standard conditions (http://www.hyline.com
/userdocs/Hy-LineBrown.pdf). Throughout the trial, only on
day 6 were the bird weights for the control group significantly
greater than those of the Bdellovibrio-treated group, although
this difference was marginal (P 0.0404 by Student’s t test with
Welch’s correction for unequal variances); otherwise, the
weights of the birds in both groups were indistinguishable from
each other and met or exceeded industry standards (26).
Experimental Bdellovibrio was not detected in the cage en-
vironment after dosing. As the oral gavage of Bdellovibrio was
simply administered to the birds from plastic syringes without
a needle or cannulum (the birds then were returned to their
floor pens), it was possible that Bdellovibrio organisms in the
birds’ mouths would find their way into the shared water dis-
penser and feed bowl of that group of birds, or that Bdellovibrio
which survived passage through the intestinal tract would enter
the environment in the birds’ fecal deposits. As each treatment
group of birds in our experiment was housed in pens within
contained, biosecure rooms, cross-contamination was not an
issue. However, we wished to see whether Bdellovibrio could be
detected in the food and water of the birds to inform bird-
housing considerations were Bdellovibrio to be practically ap-
plied as a therapy. Bdellovibrio is isolated from environmental
water and soil sources (28, 29, 55), so it was possible that they
could survive our dosing, and also it was possible that naturally
occurring Bdellovibrio was present in the water and bedding
and on the birds themselves (none of which were germfree).
Our sampling was aimed to detect any excess of Bdellovibrio in
the dosed birds versus that in controls, but no Bdellovibrio
organisms were isolated from any sample in this experiment.
The bacterial populations recorded in the fecal and water
samples did not reveal any consistent differences between the
control and Bdellovibrio-treated groups (data not shown).
Alterations to the native cecal bacterial populations by
Bdellovibrio. Testing the fecal pellets did not reveal Bdellovibrio
transiting the bird guts; however, in cecal contents taken from
dissected birds at the end of the trial (28 days), blood agar and
Rogosa plate counts (indicative of total culturable anaerobic
and Lactobacillus populations, respectively) (Fig. 2B) were sig-
nificantly lower (P 0.0029 and 0.0095, respectively) in Bdello-
vibrio-treated birds than in the untreated control group (Stu-
dent’s t test with Welch’s correction for unequal variances).
Conversely, counts on mitis salivarius agar (indicative of cul-
turable fecal streptococcal populations) were significantly
higher in the cecal contents of Bdellovibrio-treated birds than
in those of the controls (P  0.0008). The counts of both the
culturable bifidobacteria and coliform populations showed no
differences between the two groups (Fig. 2B). However, Bdel-
lovibrio was not recovered from the Bdellovibrio-dosed fecal
samples throughout the trial or the samples of cecal content at
the end of the trial. This suggests that Bdellovibrio is, at most,
a short-lived population in the chicken intestine and does not
readily contaminate the immediate environment of the birds.
The significant changes in the culturable bird gut microbiota
were taken as evidence of Bdellovibrio activity in the ceca just
after inoculation, having effects on gut flora which persisted
long enough to be measured at 28 days. A fuller DNA-based
study of the whole microbiotal contents (including viable non-
culturable species) is warranted on the basis of these detected
changes in culturable populations, but this was beyond the
scope of the study here.
Bdellovibrio reduces Salmonella colonization in chicks. A
scatter plot (Fig. 3) showing the distribution of Salmonella
counts (in log10 CFU g
1) in the cecal contents of control and
predatory HD Bdellovibrio-treated birds shows that in all three
days of the trial, the control groups harbored significantly
higher numbers of Salmonella in their cecal contents than
predatory HD Bdellovibrio-treated birds (P  0.004). The
mean reduction in Salmonella numbers in the ceca of Bdello-
vibrio-treated animals compared to treatment with the buffer
controls was 0.76, 1.09, and 0.64 log10 CFU g
1 for days 1, 2,
and 3 of the trial, respectively. In contrast, there were no
statistically significant differences between Salmonella counts
in the nonpredatory HI pilA Bdellovibrio-treated birds and
those given a buffer control (Fig. 3). However, on days 1 and 2
there was a significant difference (P  0.05) between the mean
Salmonella numbers for the HD Bdellovibrio-treated birds and
the nonpredatory HI pilA Bdellovibrio-treated birds, with the
HD Bdellovibrio-treated birds showing a mean reduction of
0.47 and 0.78 log10 CFU g
1 for days 1 and 2 compared to
levels for the HI pilA Bdellovibrio-treated birds. This con-
firmed a predatory effect on those 2 days.
Bdellovibrio reduces cecal abnormalities and results in in-
creased weight of cecal contents. It has been published previ-
ously by others that the Salmonella Enteritidis PT4 infection of
chicks causes full white ceca due to infiltration by white blood
cells (1, 2, 16, 36, 42). We found these cecal abnormalities in
our studies. Ceca were classified as abnormal if they were small
(weighing less than 0.1 g) or were solid and white or white and
mucoid, with almost no dark, free-flowing contents. The pro-
portion of cecal abnormalities from control chicks and preda-
tory HD and nonpredatory HI Bdellovibrio-treated chicks were
compared for statistically significant differences using Fisher’s
exact test (Table 1), and typical examples of abnormal and
normal ceca were photographed (Fig. 4). No significant differ-
ences in the proportion of cecal abnormalities were seen be-
tween the control group and the nonpredatory pilA mutant
HI Bdellovibrio-treated groups on any of the three days following
treatment. However, birds treated with predatory HD Bdello-
vibrio harbored a significantly smaller proportion of abnormal
ceca than the control on two of the three days (Table 1).
The weight of cecal contents from control and HI pilA
nonpredatory Bdellovibrio-treated birds as well as HD preda-
tory Bdellovibrio-treated birds were analyzed using the non-
parametric Kruskal-Wallis test with Dunn’s post test (51). A
significant (P  0.05) increase in the weight of cecal contents,
accompanying the observation of free-flowing normal dark ce-
cal contents, was seen in the HD predatory Bdellovibrio-treated
birds on the first 2 days following treatment, compared to that
with the buffer control (Table 2).
DISCUSSION
Bdellovibrio strains have long been proposed as a future
alternative for antimicrobial therapy, and it has been suggested
that they would be suitable for external use (such as in infected
skin wounds [52]); however, in such applications the accidental
ingestion of Bdellovibrio may be an issue. Bdellovibrio species
are reported to be unable to prey on eukaryotic cells, and as
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such they pose no direct risk to human or animal health, but
the indirect consequences of their predation on the natural
microbiota of a treated animal or human may be detrimental
to health. Our study is the first in which Bdellovibrio strains
have been used internally in a live-animal model to reduce
pathogen numbers in vivo, and it provides the first insights into
their potential effects on the native gut flora should they be
accidentally ingested.
We have shown that Bdellovibrio bacteriovorus HD100 is a
good predator in in vitro assays on Salmonella Enteritis
P125109 prey, effectively reducing Salmonella numbers by 97%
during a 24-h incubation period (Fig. 1). S. Enteritidis P125109
is a phage type 4 (PT4) strain that was isolated from a food-
FIG. 3. Scatter plot showing the effect of Bdellovibrio treatment on
colonization of chicken ceca by Salmonella Enteritidis. Ten groups of
18 Hy-line brown chicks each were challenged orally with approxi-
mately 3  107 CFU of S. Enteritidis P125109 at 2 days of age. Four
of these groups subsequently were dosed orally with approximately
9.8  107 PFU of Bdellovibrio bacteriovorus HD100 at 6 days of age.
Two further groups were dosed with nonpredatory HI pilA Bdello-
vibrio, matched to the predatory Bdellovibrio number by total protein
content. During each of the 3 days following Bdellovibrio treatment, six
birds from each group were sacrificed, and the number of Salmonella
organisms in the cecal contents of each bird was determined by spread-
plating serial dilutions of cecal suspensions onto brilliant green agar.
The results from four independent biological repeats were pooled
from each day. Each data point represents the number of Salmonella
organisms in the cecal contents of a single bird. The horizontal line
represents the means for each group.
FIG. 4. Representative ceca from treated birds. (A) Predatory HD
Bdellovibrio-treated bird; (B) nonpredatory HI pilA Bdellovibrio-
treated bird; (C and D) control birds. Scale bars, 5 cm. Normal ceca
contain dark free-flowing fecal material, but Salmonella infection is
widely reported (1, 2, 16, 36, 42) to cause pale ceca with dense non-
free-flowing contents due to inflammation and white blood cell
infiltration.
TABLE 1. Changes to cecal morphology and pigmentation in
treated and control birdsa
Treatment
No. of cecal abnormalities/total no. of
birds (P) on day:
1 2 3
Control buffer 9/24 9/24 8/26




4/12 (NS) 2/12 (NS) 2/13 (NS)
a Shown are the number of cecal abnormalities in each treatment group on
each day following treatment. Statistical analysis of each group compared to the
control was performed using Fisher’s exact test, and P values less than 0.05 are
given. NS, nonsignificant (P  0.05).
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poisoning outbreak linked to a poultry farm, and it has been
shown to be highly virulent in young chicks and to be invasive
in laying hens, resulting in contaminated eggs (5, 6, 58). Many
strains of Salmonella Enteritidis are known to be capable of
passing between host species, increasing the potential for out-
breaks as they pass from animals to humans, and those belong-
ing to the PT4 groups are primarily responsible for salmonel-
losis outbreaks in Europe (40). Thus, the Salmonella strain
used in this study is of relevance to both human and animal
disease, and it has been responsible for real outbreaks of dis-
ease.
Dosing 2-day-old (Salmonella-free) chicks with wild-type
predatory B. bacteriovorus HD100 did not cause any observable
negative health effects on the birds, which continued to eat,
drink, and behave normally; they grew (Fig. 2A) at a rate
comparable to that of birds of the same strain reared under
standard poultry industry conditions (26).
We were able to show in vitro that at least a portion of the
B. bacteriovorus HD100 population survived anaerobic and
microaerobic incubations at 42°C for 48 h, and it retained
predatory capability; thus, the atmospheric and temperature
conditions that they would experience in the cecum would not
rapidly kill them, although they were clearly not active within
the gut flora after 26 days in our well-being experiment. That
there were long-lasting changes in the culturable gut flora of
birds following a single Bdellovibrio dose at 2 days was some-
what unexpected, but it was clear that the changes were asso-
ciated with only positive or neutral impacts on bird well-being
(Fig. 2B). The unexpected increase in counts on the mitis agar
(taken to be streptococcal, Gram-positive bacteria) for the
Bdellovibrio-treated birds in the well-being experiment may
have been due to a niche becoming available due to a preda-
tory reduction in Gram-negative bacteria, which was recorded
as a reduction in total anaerobic counts (Fig. 2B). Previous in
vitro studies (25) of Bdellovibrio predation in mixed cultures
containing both susceptible prey (E. coli) and live decoys of
nonsusceptible Gram-positive bacteria (in that case, nonspo-
rulating Bacillus subtilis) showed that in cultures containing all
three species of bacteria, a rise in both prey and live decoy
numbers occurred due to the recycling of nutrients released
from the remnants of burst prey and dead Bdellovibrio cells,
showing that Bdellovibrio predation can indirectly affect other
bacterial populations which are not susceptible to predation
(25). To reduce our use of birds to the minimum number
possible, we decided not to investigate this change further, as
we were confident from the growth data and well-being of the
birds that any effects of this Bdellovibrio-induced change in the
culturable microbiota which we studied here were not detri-
mental. Future DNA-based studies examining the total gut
microbiota and the effect of Bdellovibrio predation upon it
would be interesting and important to fully measure the effects
(56).
Our results have shown that orally dosing chicks with pred-
atory wild-type Bdellovibrio bacteriovorus HD100, but not a
nonpredatory pilA strain (18) (reconfirmed here by silent
deletion), is associated with a significant reduction in the num-
bers of Salmonella organisms in the cecal contents of live-
infected chickens compared to results for the untreated con-
trols (Fig. 3). In addition, only birds treated with predatory
wild-type Bdellovibrio had a significantly smaller proportion of
abnormal ceca (which showed inflammatory characteristics de-
scribed previously [1, 2, 16, 36, 42]) than that of untreated
controls (Table 1 and Fig. 4).
Birds treated with the nonpredatory pilA strain of Bdel-
lovibrio did not show any significant reduction in Salmonella
numbers compared to the control group, nor were the numbers
of abnormal ceca reduced compared to those given for the
buffer control. It was noted that the birds in the pilA-treated
group showed a small (but nonsignificant) improvement in
cecal mass and appearance; thus some, but not all, of the
therapeutic effects seen by predatory Bdellovibrio treatment
may be due to competition for resources, including nutrients
and the limited available oxygen.
That many of the Salmonella-treated birds which did not
receive predatory Bdellovibrio had pale ceca with abnormal
dense white mucoid gut material within suggested that the
untreated Salmonella had caused the inflammation of the ceca
and recruitment of heterophils to that area of the gut, as others
have reported (1, 2, 16, 36, 41, 42). It was marked how treat-
ment with predatory Bdellovibrio, but not the pilA strain, had
ameliorated this effect (Table 1 and Fig. 4). This observation
should be followed up by further histological studies. In addi-
tion, the cecal contents of predatory Bdellovibrio-treated birds
were of a normal color and consistency compared to the pale,
solid material often contained within the ceca of untreated
control birds. This may have resulted in an underrepresenta-
tion of Salmonella numbers in the latter, as access to the cecal
lumen (from which the material for counting was sampled) was
restricted by the viscosity of the pale solid material in the cecal
cavity.
In these poultry trials we were not able to readily culture
Bdellovibrio from the cecal contents of birds, although we did
recover some live Bdellovibrio sporadically in a pilot stage of
the trial in younger 6- to 9-day-old birds (see Fig. S2 in the
supplemental material). However, we were able to record their
effects on culturable gut microbiota in the well-being experi-
ment (Fig. 2B) and on the reduction of abnormal cecal num-
bers and Salmonella colonization in the therapeutic trial (Table
TABLE 2. Weights of cecal contents from each treatment group following Bdellovibrio treatmenta
Treatment
Cecal content wt (means 	 SD) on day:
1 2 3
Control buffer 0.49	 0.28 0.48 	 0.37 0.77	 0.46
HD Bdellovibrio 0.75 	 0.30 (P  0.05) 0.87 	 0.51 (P  0.01) 0.94	 0.49 (NS)
HI Bdellovibrio nonpredatory pilA 0.84 	 0.48 (NS) 0.72	 0.50 (NS) 1.08	 0.54 (NS)
a A nonparametric Kruskal-Wallis with Dunn’s post test was performed on each group versus the control group, and P values versus the control for statistically
significantly different groups are shown. NS, nonsignificant (P  0.05).
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1). It was clear that by day 3 of our trial the effects of the HD
Bdellovibrio were waning, presumably because they were short
lived.
The most characteristic postmortem finding was abnormal
ceca (i.e., typhlitis), seen in approximately one-third of birds
dying of nontyphoidal salmonellosis, with the ceca distended
by hard, white, necrotic cores (1, 2, 16, 36, 42), and it is clear
(Table 1) that predatory HD Bdellovibrio ameliorated this ef-
fect. Comparisons to nonpredatory Bdellovibrio and the buffer
control showed that live predatory Bdellovibrio bacteria were
producing a reduction in Salmonella numbers, albeit modestly,
by 1 log10. This is the first time that the reduction of pathogens
by Bdellovibrio has been shown in live animals.
For an ideal treatment, multiple rounds of Bdellovibrio rep-
lication on the Salmonella prey in the gut would be required to
eradicate the Salmonella rather than to simply reduce their
numbers, but our study is a good start in that direction and has
used the minimum number of birds possible to show a statis-
tically significant effect. In future studies, the isolation of novel
gut-associated Bdellovibrio strains may give increased preda-
tion efficiency in these hot, anoxic environments against Sal-
monella. We used the type strain of Bdellovibrio, HD100, as it
showed good in vitro predation efficiency on our chosen Sal-
monella strain and as its biology has been the subject of most
recent studies. Bdellovibrio species have been isolated from the
feces of both humans and animals, including chickens (47), but
their predatory activity on a range of gut pathogens and com-
mensals has not been extensively analyzed. The further inves-
tigation of such strains may reveal that there are Bdellovibrio
species which are more suitable for use in the gut setting, and
they may improve on the reduction in pathogen numbers seen
here.
Nevertheless, our mild therapeutic effect can be compared
to those of previous studies of bacteriophage treatment of
Salmonella in live birds. Salmonella-specific bacterial viruses
(bacteriophages) have been used both prophylactically (8, 9)
and therapeutically (3, 7, 59) to prevent/reduce the coloniza-
tion of the chicken gastrointestinal tract. The efficacy of bac-
teriophage treatment in young birds (less than 30 days of age)
varied from modest (21) to moderate reductions of 1 to 2 log10
CFU g1 cecal contents (7). A treatment using solely phage
P22 tail spike protein against Salmonella enterica serovar Ty-
phimurium colonization of 2-day-old chicks showed a 2-log
reduction in Salmonella numbers if the treatment was admin-
istered 1 h after Salmonella gavage and a 1-log reduction if
administered 18 h after Salmonella dosing (62). Thus, the re-
duction achieved in our first Bdellovibrio trial is not out of line
with the reductions seen using other biocontrol agents in sim-
ilar models and may be improved by further multiple dosings.
Thus, while we acknowledge that more studies on the level
and number of doses of Bdellovibrio required to effect a greater
reduction or the possible eradication of Salmonella, we are
glad to have made this start with Bdellovibrio being tested for
its in vivo effects. Our study has shown that Bdellovibrio species
do survive gut conditions for a short while and for long enough
to have a beneficial therapeutic effect, and this can be built
upon. We have also shown that, in this model at least, Bdello-
vibrio species do not have a detrimental effect on the health
and well-being of noninfected birds, although some changes to
the commensal gut flora are seen. The way ahead for improv-
ing Bdellovibrio for therapeutic applications is clear, and our
study of birds suggests that there is no need to fear negative
consequences on the gut microbiota if, during use as an exter-
nal treatment, Bdellovibrio species were to be accidentally in-
gested.
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